Reinvestigating a natural antibiotic compound reveals its potential as a tuberculosis drug.
Advertisement
The Scientist
Most Recent
As federal budgets tighten, the US government is getting serious about enforcing reporting and administrative rules that accompany academic grants.
A new study of the scientific literature finds that researchers are guilty of overemphasizing the benefits of medical treatments.
A cheap pain reliever that can kill drug-resistant, tuberculosis-causing bacteria may never be tested.
Doctors question whether a government initiative to speed approval for promising new drugs is ensuring safety.
A phylogenetic study of traditional plant remedies could aid drug development.
Professional dialogue between scientists and non-scientists is not easy, but when successful, it can create powerful insights and relationships.
The federal agency is shuffling around its programs to streamline management and promote international scientific collaboration.
In his latest book, author John Coates describes the tension and exultation of the trading floor from a biological perspective.
Wired for Story, Dreamland, Homo Mysterious, and Vagina
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
